dm+d
416248007
Medicine Compliance Aid Stability
BaracludeBristol-Myers Squibb Pharmaceutical Ltd
Bristol-Myers Squibb Pharmaceutical Ltd
Baraclude
Tablets 500mcg, 1mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in original carton. Protect from light
9 November 2022
Lactation Safety Information
Lamivudine, Tenofovir
No published evidence of safety
Serious adverse effects reported in adults
For hepatitis B infection
Likely to pass into breast milk but quantity unknown
4 August 2020